The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- T. Zuberbier, W. Aberer, M. Maurer
- MedicineAllergy. European Journal of Allergy and Clinical…
- 25 June 2018
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence‐based diagnostic and therapeutic approaches for the different subtypes ofUrticaria.
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
- T. Zuberbier, W. Aberer, M. Maurer
- MedicineAllergy. European Journal of Allergy and Clinical…
- 1 July 2014
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence-based diagnostic and therapeutic approaches for the different subtypes ofUrticaria.
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Omalizumab diminished clinical symptoms and signs of chronic idiopathic urticaria in patients who had remained symptomatic despite the use of approved doses of H-antihistamine therapy (licensed doses).
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1
- M. Maurer, K. Weller, T. Zuberbier
- MedicineAllergy. European Journal of Allergy and Clinical…
- 1 March 2011
A GA2LEN task force report concluded that chronic spontaneous urticaria is a “hidden epidemic” that needs to be addressed to address the unmet clinical needs of patients.
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
- T. Zuberbier, W. Aberer, M. Maurer
- Medicine
- 6 May 2015
This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomecha.
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
- M. Cicardi, W. Aberer, B. Zuraw
- MedicineAllergy. European Journal of Allergy and Clinical…
- 1 May 2014
Four types of acquired and three types of hereditary angioedema were identified as separate forms from the analysis of the literature and were presented in detail at the meeting.
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
- A. Kaplan, D. Ledford, K. Rosén
- MedicineJournal of Allergy and Clinical Immunology
- 27 June 2013
Symposium on the definition and management of anaphylaxis: summary report.
- H. Sampson, A. Muñoz-Furlong, C. Camargo
- MedicineJournal of Allergy and Clinical Immunology
- 1 March 2005
Pathways for bradykinin formation and inflammatory disease.
- A. Kaplan, K. Joseph, M. Silverberg
- Biology, MedicineJournal of Allergy and Clinical Immunology
- 1 February 2002
The role for bradykinin in allergic rhinitis, asthma, and anaphylaxis is to contribute to tissue hyperresponsiveness, local inflammation, and hypotension.
Chronic urticaria: pathogenesis and treatment.
- A. Kaplan
- Medicine, BiologyJournal of Allergy and Clinical Immunology
- 1 September 2004
...
...